Missouri [US], October 20 (ANI): After 14 months, there is a 70-80 per cent risk that non-small cell lung cancer, one of the two primary types of lung cancer, would become resistant to the pharmacological therapy that was initially used to treat it. There aren't many existing therapy alternatives if it occurs.
Columbia [US], October 20 (ANI): When a person is diagnosed with non-small cell lung cancer, one of the two primary types of lung cancer, there is a 70-80 per cent risk that cancer will acquire resistance to the initial medication therapy used to treat it after 14 months. If this occurs, there aren't many therapy choices right now. Researchers are on a mission to discover a solution.
\
\
\
\
